Human recombinant ENA 78/CXCL5 (from E. coli)
Supplier: Shenandoah Biotechnology
Epithelial-derived neutrophil-activating peptide 78 (ENA 78), also known as CXCL5, is a chemokine that recruits neutrophils, promotes angiogenesis.
- Produced from genetically modified E. coli
- Stimulates connective tissue remodelling
- Monomeric protein, contains 74 amino acids
ENA 78 production is stimulated by interleukin 1 (IL-1) or tumor necrosis factor alpha (TNFα), and signals through the chemokine receptor CXCR2.
ENA 78, 5-78 aa is one of three naturally occurring ENA 78 variants in which the N-terminus has been truncated.
Delivery information: A Certificate of Analysis (COA) is supplied with each product shipped detailing purity, formulation, biological activity, endotoxin levels, reconstitution instructions and recommended storage conditions.
Caution: This product is for research use only and is not for use in humans.
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...